42
Conditi
ons
- Th
ese
remed
ies
are
p
ro
v
id
ed on
co
nd
itio
n th
at: (i
) L-3
C
IP i
s promp
tly no
tified
i
n
writing
(in
any
fo
rmat
reaso
n
ab
ly
re
qui
re
d
b
y
L-
3 C
IP)
o
f t
h
e pa
rt
ic
ul
ar
n
o
n–c
o
n
fo
rm
anc
e o
f t
h
e Pr
o
duc
ts
as del
iv
er
ed
by
L-
3
CIP; (ii) Remark
eter certifie
s th
at
all
cop
ies o
f
th
e return
ed
Program
s h
av
e b
een
d
estro
y
ed
; (iii) L-3 CIP’s
exami
n
at
io
n
o
f suc
h
P
rod
uct
s
di
scl
o
ses
t
h
at
s
u
ch
n
o
n–c
o
n
fo
rma
n
ce act
ual
ly e
x
is
te
d
wi
th
in
t
h
e wa
rra
nt
y
peri
od;
and
,
(i
v)
R
ema
rket
er
del
ivers
t
h
e P
ro
d
u
ct
s t
o
L-
3 C
IP’s
de
si
gnat
ed l
o
ca
ti
o
n
, at
R
emar
k
et
er
’s ri
sk
a
n
d e
x
p
ense.
All su
ch
remedies are av
ailab
le on
ly
i
n
the Un
ited
Stat
es a
n
d Ca
nada
.
Any Product ret
u
rns t
h
at are
not
valid
warran
ty
claims will b
e returned
to
Remark
et
er at Remark
et
er’s exp
en
se.
L-3 CIP’s liab
ility
for
d
amag
es to
Remark
eter for an
y cau
se wh
atso
ev
er, an
d reg
ard
less
of th
e fo
rm
o
f actio
n
,
whet
her in c
ontract, tort
or indemnity
, shall be
limited
to
direct
da
mage
s,
and s
h
all not e
x
ceed the
purc
hase
price
for th
e p
articu
lar items
o
f Prod
u
cts inv
o
lv
ed. Th
e fo
rego
ing limitatio
n
of liab
ility
will no
t
ap
p
ly
to th
e p
ay
m
en
t of
dama
ges a
n
d c
o
sts in accorda
n
ce
with the
Pa
ragrap
h e
n
titled Pate
nt and C
o
pyr
ight Inde
mnification.
IN
N
O
E
V
E
N
T SH
AL
L L
-3
CIP
OR I
T
S L
ICENS
ORS BE
LI
ABLE
FOR
IN
D
IRECT,
IN
CI
DEN
T
A
L
OR
CONS
EQ
UE
N
T
IA
L
DA
M
A
GES,
L
O
SS
O
F
PRO
F
IT
S,
L
O
SS
O
F
USE
OR D
A
T
A
OR
IN
TERRU
PTI
O
N
O
F
BUSI
NES
S
,
WH
ETH
ER S
U
CH
ALL
E
G
E
D
DA
M
A
GE
S ARE
L
A
BE
LED
IN
T
O
RT
, CO
NTRAC
T
OR
IN
DE
MN
IT
Y,
EVE
N
IF L-
3 CIP OR
IT
S
L
ICENS
ORS H
AVE
BEE
N
A
D
V
ISE
D OF
T
H
E
P
O
S
S
IB
IL
ITY
O
F
SU
CH DAMAG
ES, EX
CEPT A
S
PRO
V
ID
ED
I
N
THE P
A
RAGRAPH
ENT
ITLE
D P
A
TE
NT
AND
COPYR
IG
H
T
IN
DE
MN
IF
IC
ATI
O
N.
Actions,
howe
ver asserte
d
,
shall be comme
nced
within
tw
o yea
rs
from t
h
e date the
ca
use
of action accrues;
pr
o
v
id
ed
,
h
o
w
ever
, a
n
act
io
n
fo
r
no
n
p
ay
men
t may
be c
o
m
m
ence
d at
a
n
y
ti
m
e wi
th
in
f
o
ur
yea
rs
fr
om
t
h
e
dat
e t
h
e
cause
of action accrues.
Summary of Contents for 3261607 Thermal-Eye 250D
Page 37: ...37 Notes ...
Page 38: ...38 Notes Continued ...
Page 39: ...39 Warranty Information L 3 COMMUNICATIONS INFRARED PRODUCTS ...